Yüklüyor......
Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
OBJECTIVE: It is known that patients with diabetes are susceptible to cancer development due to long-standing diabetic conditions. This study aimed to investigate new-onset cancer risk associated with dipeptidyl peptidase-4 (DPP-4) inhibitors as compared to metformin, the first-line antidiabetic age...
Kaydedildi:
| Yayımlandı: | Cancer Manag Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6689554/ https://ncbi.nlm.nih.gov/pubmed/31496802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S215107 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|